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Abstract:
Background: Ginkgo Bilboa injection has had been clinically applied to restore the damaged cells and tissues due to the 
ischemia through improving the cerebral blood supply and decreasing the oxygen consumption.
ObjectiveAim: To evaluate the Ginkgo Bilboa injection's therapeutic role towards ischemia/ reperfusion (I/R) injury 
through determination of  monoamine neurotransmitter dopamine (DA) in corpus striatum.
Methods: After the incomplete global cerebral ischemia and reperfusion models were prepared, rats were randomly assigned 
into four groups: sham-operated group, ischemia-reperfusion group, nimodipine injection group, and Ginkgo Biloba injec-
tion group. The cerebrospinal fluid in the rat brain striatum at different time points was collected with microdialysis, and the 
level of  monoamine neurotransmitters dopamineDA was determined by high performance liquid chromatography (HPLC) 
with electrochemical detector (ECD).
Results: The dopamineDA content in cerebral ischemia model group was significantly higher than that in the sham-operat-
ed group (P<0.05) at the 30 min. However, the DA level in nimodipine injection group and Ginkgo Biloba injection group 
were lower than the model group (P<0.05). The dopamineDA level in Ginkgo Biloba injection group gradually decreased, 
and was significantly different from the model group (P<0.05).
Conclusion: Ginkgo Biloba injection can could significantly inhibit brain I/R injury, as demonstrated by prevention of  
excessive release of  dopamineDA in striatum.
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Introduction
Ischemic cerebrovascular disease occurs occured when 
the blood vessel is was blocked, and it is was often re-
sulted from a clot formed from fat and cholesterol. 
During ischemic cerebrovascular disease, the brain cells 
suffered from the lack of  nutrients and oxygen due to 
the difficulty of  blood to reach brain. Ischemic cere-
brovascular disease has had been regarded as one of  
the most severe diseases that lead to death 1. After the 
restoration of  blood flow in the patients with cerebral 
stroke, cerebral ischemia-reperfusion (I/R) injury often 
occursoccurred, resulting in more severe neurological 
deficits2. I/R injury has had been closely related with 
 * Corresponding author: 
    Jin Gu,
   Traditional Chinese Medicine Pharmacy of     
   PLA General Hospital, 
   28# Fuxing road Beijing, 100853, China
   E-mail: GuJin20130331@163.com
 
imbalance of  ions, free radicals, and inflammatory re-
sponses 3. 
Dopamine (DA) is was an important monoamine neu-
rotransmitter and hormone, and has had been demon-
strated to play various important physiological roles 
4. Cerebral ischemia can could induce the release of  
dopamineDA in corpus striatum, and the pre-depletion 
of  dopamineDA in corpus striatum can could protect 
I/R injury. Additionally, some studies have had found 
that dopamineDA plays played a key role in regulating 
the neurogenesis 5. The monitoring of  dopamineDA 
level in corpus striatum can could well reflect the extent 
of  injury, and will would be helpful for understanding 
the therapeutic role of  drugs towards I/R injury.
The injection containing Ginkgo Bilboa extract has had 
been demonstrated to exhibit multiple pharmacologi-
cal activities, including anti-oxidant, elevation of  blood 
flow. The present study aims aimed to evaluate the in-
fluence of  Ginkgo Bilboa injection towards the levels 
of  dopamineDA in corpus striatum of  rats with I/R 
injury using the combination methods of  microdialy-
sis (MD) and high performance liquid chromatography 





Ginkgo Bilboa injection (batch number: E7161) was 
purchased from Zhonghao international company. Ni-
modipine injection (batch number: BXFH2D3) was 
obtained from Bayer company. DopamineDA was ob-
tained from national institutes for food and drug con-
trol. 
Animals and treatments:
Male SD rats (170-210 g) were purchased from General 
Hospital of  the Chinese People's Liberation Army. The 
animals were cared for according to the Animal Facility 
Guidelines of  General Hospital of  the Chinese Peo-
ple's Liberation Army. 
The rats were divided into 4 groups, and each group 
included 6 rats. One group was sham-operated group. 
One group was ischemia-reperfusion model in which 
the animals were given ischemic preconditioning fol-
lowed the ischemia-reperfusion injury procedure (por-
tal triad clamping for 30 min, and blood flow restora-
tion for 30 min). One group was nimodipine injection 
group in which 4.5 mlmL/kg injection (i.p.) was given 
before the establishment of  model. The final group was 
Ginkgo Bilboa injection group in which 0.9 mlmL/kg 
injection (i.p.) was given before the establishment of  
model. All the rats received intraperitoneal injection 
once. All experiments were completed in the animal ex-
perimental center of  People's Liberation Army General 
Hospital. Experiments were conducted in accordance 
with animal ethical requirements.
Microdialysis sampling
All collections were made in a Raturn (BASi, West La-
fayette, IN) while the animal kept awake and acitve 
freely. Collections probes were acutely implanted after 
surgery. Using a syringe pump (BASi BEE), a 30 min 
flush was performed through the microdialysis probe 
at 1 μL/min after which collections began at 1 μL/min 
for 60 min for 5 hours. Samples were stored on ice, and 
kept frozen at -80oC until analysis.
The analysis of  dopamine (DA) using HPLC-ECD 
method
The separation of  dopamine (DA) was performed using 
HPLC. The Eclipse XDB-C18  column (250mm ×4.6 
mm, 5μm) was used, and the mobile phase contained 
85 mM citric acid, 100 mM sodium acetate, 0.2 mM 
Na2-EDTA, 0.9 mM octane sulfonic natrium, 300 mL 
methanol (pH=3.7). The elute velocity was 1 ml/min, 
and the column temperature was maintained at 35oC. 
The applied potentials (mV): conditioning cell = +10 V; 
analytical cell, E1 = +50 V; E2 = +340V.
Statistical analysis
The data was given as mean±S.D. Statistical differences 
were evaluated using the two-tailed Student’s t-test and 
considered significant at the *p < 0.05 level.
Results:
Method development:
20 μL dopamineDA was injected and analyzed using 
several concentrations (3.2 ng/mL, 8 ng/mL, 16 ng/
mL, 40 ng/mL, and 80 ng/mL). The representative 
chromatography figure was given in Fig. 1. The linear 
regression equation was Y =80.2080X-5.4924, in which 
Y represented the peak area, and X represented the 
Table 1 The alteration of  DA concentrations in rat brain (mean±S.D., n=6), unit: ng/mL 
Groups Time/min 









140 160 180 200 220 240 
Ⅰ 27.4±7.9 34.6±27.8 25.5±11.6 22.3±12.7 20.3±5.7** 29.5±13.4 28.6±15.3 19.7±6.1* 31.8±11.1 31.9±15.8 18.7±8.9 
Ⅱ 25.3±1.6 29.0±1.8 23.9±3.6 24.9±3.4 95.7±9.2 23.6±10.2 21.4±6.1 43.0±20.3 27.4±17.3 22.9±13.6 17.2±11.8 
Ⅲ 28.0±2.3 32.3±20.9 27.0±4.9 38.2±18.2 32.5±24.3** 39.7±29.0 49.8±18.4* 40.5±13.2# 23.9±16.2 24.3±14.4 17.6±12.9 
Ⅳ 24.4±4.9 32.8±5.1 28.3±7.3 31.2±6.0 54.5±22.7*,# 40.5±7.2* 32.3±7.8 30.7±9.4 35.3±3.7 28.8±4.0 27.5±6.5 
*,p<0.05;**, P<0.01; compared with model group; #,P<0.05, compared with sham-operated 
group. 
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concentration of  dopamineDA. The coefficient was 
calculated to be 0.9997. The intraday relative standard 
deviation (RSD) was 2%, and inter-day RSD was 2.8%. 
The recovery exercise was determined at low, medium 
and high concentrations of  QC samples, and the values 
were calculated to be 96.67% 106.00% and 92.50%, re-
spectively. 
The influence of  Ginkgo Bilboa injection towards the 
DA level in brain
Based on the established analytical approach, the con-
centrations of  DA in striatum of  rat brain from the 
different sampling point were tested (Fig 2). At the 
same time, the DA level in brain was determined at 
the different sampling time, and the results were given 
in Table 1. The DA level in corpus striatum remained 
Figure Legends 
Fig.1 Representative figures for determination of  different concentrations of  dopamine (DA).  
Fig.2 Chromatograms of  DA concentration in aCSF from different group. A: sham-operated 








stable between 0 and 60 min in which the treatment 
was not given. The i.p. administration of  Ginkgo Bil-
boa injection and nimodipine injection was began at 
60 min. After 30 min administration, the concentration 
of  DA was higher in Ginkgo Bilboa injection group 
and nimodipine injection group. However, no signifi-
cant difference was observed between treatment group 
and model group. At 90 min, ischemia model was con-
structed, and after 30 min, comparing with sham-oper-
ated group, the DA level in ischemia model exhibited 
significantly higher (p<0.01). The DA level in Ginkgo 
Bilboa injection group (p<0.01) and nimodipine injec-
tion group (p<0.05) was much lower than model group. 
At 120 min, the reperfusion was performed. The DA 
level in ischemia model group immediately decreased 
to pre-ischemia DA level. At 180 min, the DA level in-
creased, and then recovered to normal level. Different 
from the model group, the DA level in Ginkgo Bilboa 
injection group showed gradually decrease trend, and 
did not exhibit the recovery phenomena. 
 
Discussion
Cerebral ischemia-reperfusion (I/R) injury has had 
been considered as the major pathogenic mechanism 
of  various cerebrovascular diseases 6. For the tradi-
tional method, the determination of  neurotransmitter 
needs needed to take brain tissue through decapitat-
ing the rats. Additionally, the precipitation of  protein 
was needed after homogenization of  brain tissues. This 
method is was very complicated, and needs requried 
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large numbers of  experimental animals. Microdialysis is 
was a relatively novel sampling technique which has had 
extensively applied in neurotransmitter research, partic-
ularly in  the determination of  monoamine and amino-
acid neurotransmitters 7. In combination with the rapid 
development of  some analytical methods (e.g. liquid 
chromatography, mass spectrometry, electrochemical 
detection, etc), themicrodialysis methodology has had 
been successfully applied in neurochemistry 8.
In the present study, this technology was employed to 
investigate the therapeutic role of  Ginkgo Bilboa injec-
tion towards cerebral ischemia-reperfusion (I/R) injury. 
Similar with the results reported by Li et al.9, in the 
I/R injury model, the concentration of  DA sharply in-
creased to the peak value after 30 min ischemia. After 
the reperfusion, the concentration rapidly decreased to 
the normal level. After cerebral ischemia, nimodipine 
injection and Ginkgo Biloba injection significantly pre-
vent the elevation of  DA level, indicating that these two 
injections can efficiently control the metabolic disor-
ders of  DA. During reperfusion process, the influence 
of  nimodipine injection and Ginkgo Biloba injection 
towards DA level exhibited different behaviors. For ni-
modipine injection group, the DA level continued to in-
crease, which might be due to the short half  life (1.1-1.7 
h) of  nimodipine injection. In Ginkgo Biloba injection 
group, the DA level gradually decreased, and DA level 
remained at the baseline level for a longer time, indicat-
ing Ginkgo Biloba injection had the more efficient than 
nimodipine injection.
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Conclusion
The present study indicated the effective treatment of  
Ginkgo Biloba injection towards I/R injury through the 
determination of  dopamineDA level alteration using 
MD-HPLC-ECD method. 
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